After May’s second defeat, ABPI calls on Parliament to avoid no-deal Brexit

The U.K. pharma body ABPI called on the U.K. Parliament to avoid a no-deal Brexit after Prime Minister Theresa May's Withdrawal Agreement was again defeated in the House of Commons by a margin of 149 votes.

Mike Thompson, CEO of the Association of the British Pharmaceutical Industry, repeated his warnings that while pharma companies have prepared for a no-deal scenario, "we could face the very real possibility of disruption to the supply of some medicines," he said...